Form 4: Director William Burke Receives Ceribell RSU Grant

Ceribell, Inc. director William W. Burke acquired 7,838 restricted stock units as part of an equity compensation grant.

Summary

• Director William W. Burke was granted 7,838 restricted stock units (RSUs) by Ceribell, Inc.
• The transaction occurred on June 2, 2026.
• Following this grant, the director's total beneficial ownership of common stock increased to 25,229 shares.
• The shares were acquired at a price of $0, consistent with standard RSU equity compensation structures.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing reflecting standard director compensation practices.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• None identified.

Risks

• Standard market risks associated with equity ownership in a publicly traded company.

Future Outlook

Not applicable as this is a routine disclosure of director equity compensation.

Industry Context

StockSavvy.ai notes that routine equity grants to board members are standard corporate governance practices intended to incentivize long-term oversight and strategic alignment within the medical technology sector.

Comparison to Industry Standards

• The grant of RSUs to non-employee directors is consistent with standard compensation practices for mid-cap medical device companies.

Stakeholder Impact

• Minimal impact on shareholders as this represents standard director compensation.

Next Steps

• Vesting of the granted restricted stock units according to the company's equity incentive plan.

Key Dates

Keywords

Ceribell, CBLL, Form 4, Insider Trading, Director Compensation, Restricted Stock Units